Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 53 entries
Sorted by: Best Match Show Resources per page
Nuedexta for the Treatment of Pseudobulbar Affect: Estimating the Financial Impact to the Scottish NHS.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Kiff C, Mealing S, Singh M, Baculea S, Badhan A, Yonan C.
PMID: 27200929
Value Health. 2014 Nov;17(7):A396. doi: 10.1016/j.jval.2014.08.889. Epub 2014 Oct 26.

No abstract available.

Cite
Kiff C, Mealing S, Singh M, et al. Nuedexta for the Treatment of Pseudobulbar Affect: Estimating the Financial Impact to the Scottish NHS. Value Health. 2014;17(7):A396doi: 10.1016/j.jval.2014.08.889.
Kiff, C., Mealing, S., Singh, M., Baculea, S., Badhan, A., & Yonan, C. (2014). Nuedexta for the Treatment of Pseudobulbar Affect: Estimating the Financial Impact to the Scottish NHS. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A396. https://doi.org/10.1016/j.jval.2014.08.889
Kiff, C, et al. "Nuedexta for the Treatment of Pseudobulbar Affect: Estimating the Financial Impact to the Scottish NHS." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A396. doi: https://doi.org/10.1016/j.jval.2014.08.889
Kiff C, Mealing S, Singh M, Baculea S, Badhan A, Yonan C. Nuedexta for the Treatment of Pseudobulbar Affect: Estimating the Financial Impact to the Scottish NHS. Value Health. 2014 Nov;17(7):A396. doi: 10.1016/j.jval.2014.08.889. Epub 2014 Oct 26. PMID: 27200929.
Copy Download .nbib Format: NLM
Lipoxygenase heterogeneity in Pisum sativum.

Planta

Domoney C, Firmin JL, Sidebottom C, Ealing PM, Slabas A, Casey R.
PMID: 24196672
Planta. 1990 Apr;181(1):35-43. doi: 10.1007/BF00202322.

Antibodies raised against two pea (Pisum sativum L. cv. Birte) seed lipoxygenases have been used to analyze lipoxygenase heterogeneity in seeds and in other organs. At least seven different polypeptides were identified in vivo; five of these were identified...

Cite
Domoney C, Firmin JL, Sidebottom C, et al. Lipoxygenase heterogeneity in Pisum sativum. Planta. 1990;181(1):35-43doi: 10.1007/BF00202322.
Domoney, C., Firmin, J. L., Sidebottom, C., Ealing, P. M., Slabas, A., & Casey, R. (1990). Lipoxygenase heterogeneity in Pisum sativum. Planta, 181(1), 35-43. https://doi.org/10.1007/BF00202322
Domoney, C, et al. "Lipoxygenase heterogeneity in Pisum sativum." Planta vol. 181,1 (1990): 35-43. doi: https://doi.org/10.1007/BF00202322
Domoney C, Firmin JL, Sidebottom C, Ealing PM, Slabas A, Casey R. Lipoxygenase heterogeneity in Pisum sativum. Planta. 1990 Apr;181(1):35-43. doi: 10.1007/BF00202322. PMID: 24196672.
Copy Download .nbib Format: NLM
The use of individual patient-level data (IPD) to quantify the impact of pretreatment predictors of response to treatment in chronic hepatitis B patients.

BMJ open

Ali S, Mealing S, Hawkins N, Lescrauwaet B, Bjork S, Mantovani L, Lampertico P.
PMID: 23355658
BMJ Open. 2013 Jan 24;3(1). doi: 10.1136/bmjopen-2012-001309.

OBJECTIVES: Evidence synthesis is an integral part decision-making by reimbursement agencies. When direct evidence is not available, network-meta-analysis (NMA) techniques are commonly used. This approach assumes that the trials are sufficiently similar in terms of treatment-effect modifiers. When imbalances...

Cite
Ali S, Mealing S, Hawkins N, et al. The use of individual patient-level data (IPD) to quantify the impact of pretreatment predictors of response to treatment in chronic hepatitis B patients. BMJ Open. 2013;3(1)doi: 10.1136/bmjopen-2012-001309.
Ali, S., Mealing, S., Hawkins, N., Lescrauwaet, B., Bjork, S., Mantovani, L., & Lampertico, P. (2013). The use of individual patient-level data (IPD) to quantify the impact of pretreatment predictors of response to treatment in chronic hepatitis B patients. BMJ open, 3(1), . https://doi.org/10.1136/bmjopen-2012-001309
Ali, Shehzad, et al. "The use of individual patient-level data (IPD) to quantify the impact of pretreatment predictors of response to treatment in chronic hepatitis B patients." BMJ open vol. 3,1 (2013). doi: https://doi.org/10.1136/bmjopen-2012-001309
Ali S, Mealing S, Hawkins N, Lescrauwaet B, Bjork S, Mantovani L, Lampertico P. The use of individual patient-level data (IPD) to quantify the impact of pretreatment predictors of response to treatment in chronic hepatitis B patients. BMJ Open. 2013 Jan 24;3(1). doi: 10.1136/bmjopen-2012-001309. PMID: 23355658; PMCID: PMC3563125.
Copy Download .nbib Format: NLM
Participation of EL2 in the donor activation of silicon implanted into GaAs.

Physical review. B, Condensed matter

Kengkan P, Mealing A, Morrow RA.
PMID: 10010779
Phys Rev B Condens Matter. 1994 Jun 15;49(23):16309-16312. doi: 10.1103/physrevb.49.16309.

No abstract available.

Cite
Kengkan P, Mealing A, Morrow RA. Participation of EL2 in the donor activation of silicon implanted into GaAs. Phys Rev B Condens Matter. 1994;49(23):16309-16312doi: 10.1103/physrevb.49.16309.
Kengkan, P., Mealing, A., & Morrow, R. A. (1994). Participation of EL2 in the donor activation of silicon implanted into GaAs. Physical review. B, Condensed matter, 49(23), 16309-16312. https://doi.org/10.1103/physrevb.49.16309
Kengkan, et al. "Participation of EL2 in the donor activation of silicon implanted into GaAs." Physical review. B, Condensed matter vol. 49,23 (1994): 16309-16312. doi: https://doi.org/10.1103/physrevb.49.16309
Kengkan P, Mealing A, Morrow RA. Participation of EL2 in the donor activation of silicon implanted into GaAs. Phys Rev B Condens Matter. 1994 Jun 15;49(23):16309-16312. doi: 10.1103/physrevb.49.16309. PMID: 10010779.
Copy Download .nbib Format: NLM
p53 overexpression is a prognosticator of poor outcome in esophageal cancer.

Oncology letters

Melling N, Norrenbrock S, Kluth M, Simon R, Hube-Magg C, Steurer S, Hinsch A, Burandt E, Jacobsen F, Wilczak W, Quaas A, Bockhorn M, Grupp K, Tachezy M, Izbicki J, Sauter G, Gebauer F.
PMID: 30881503
Oncol Lett. 2019 Apr;17(4):3826-3834. doi: 10.3892/ol.2019.10020. Epub 2019 Feb 06.

Immunohistochemistry studies on p53 inactivation in esophageal cancer are available with inconclusive results. Data on the combined effect of p53 protein accumulation and

Cite
Melling N, Norrenbrock S, Kluth M, et al. p53 overexpression is a prognosticator of poor outcome in esophageal cancer. Oncol Lett. 2019;17(4):3826-3834doi: 10.3892/ol.2019.10020.
Melling, N., Norrenbrock, S., Kluth, M., Simon, R., Hube-Magg, C., Steurer, S., Hinsch, A., Burandt, E., Jacobsen, F., Wilczak, W., Quaas, A., Bockhorn, M., Grupp, K., Tachezy, M., Izbicki, J., Sauter, G., & Gebauer, F. (2019). p53 overexpression is a prognosticator of poor outcome in esophageal cancer. Oncology letters, 17(4), 3826-3834. https://doi.org/10.3892/ol.2019.10020
Melling, Nathaniel, et al. "p53 overexpression is a prognosticator of poor outcome in esophageal cancer." Oncology letters vol. 17,4 (2019): 3826-3834. doi: https://doi.org/10.3892/ol.2019.10020
Melling N, Norrenbrock S, Kluth M, Simon R, Hube-Magg C, Steurer S, Hinsch A, Burandt E, Jacobsen F, Wilczak W, Quaas A, Bockhorn M, Grupp K, Tachezy M, Izbicki J, Sauter G, Gebauer F. p53 overexpression is a prognosticator of poor outcome in esophageal cancer. Oncol Lett. 2019 Apr;17(4):3826-3834. doi: 10.3892/ol.2019.10020. Epub 2019 Feb 06. PMID: 30881503; PMCID: PMC6403495.
Copy Download .nbib Format: NLM
Characterizing wing tears in common pipistrelles (.

Journal of mammalogy

Khayat ROS, Shaw KJ, Dougill G, Melling LM, Ferris GR, Cooper G, Grant RA.
PMID: 31379390
J Mammal. 2019 Jul 27;100(4):1282-1294. doi: 10.1093/jmammal/gyz081. Epub 2019 Jun 04.

Bats have large, thin wings that are particularly susceptible to tearing. Anatomical specializations, such as fiber reinforcement, strengthen the wing and increase its resistance to puncture, and an extensive vasculature system across the wing also promotes healing. We investigated...

Cite
Khayat ROS, Shaw KJ, Dougill G, et al. Characterizing wing tears in common pipistrelles (. J Mammal. 2019;100(4):1282-1294doi: 10.1093/jmammal/gyz081.
Khayat, R. O. S., Shaw, K. J., Dougill, G., Melling, L. M., Ferris, G. R., Cooper, G., & Grant, R. A. (2019). Characterizing wing tears in common pipistrelles (. Journal of mammalogy, 100(4), 1282-1294. https://doi.org/10.1093/jmammal/gyz081
Khayat, Rana Osama S, et al. "Characterizing wing tears in common pipistrelles (." Journal of mammalogy vol. 100,4 (2019): 1282-1294. doi: https://doi.org/10.1093/jmammal/gyz081
Khayat ROS, Shaw KJ, Dougill G, Melling LM, Ferris GR, Cooper G, Grant RA. Characterizing wing tears in common pipistrelles (. J Mammal. 2019 Jul 27;100(4):1282-1294. doi: 10.1093/jmammal/gyz081. Epub 2019 Jun 04. PMID: 31379390; PMCID: PMC6660809.
Copy Download .nbib Format: NLM
Modeling of Electric Fields in Individual Imaging Atlas for Capsular Threshold Prediction of Deep Brain Stimulation in Parkinson's Disease: A Pilot Study.

Frontiers in neurology

Béreau M, Kibleur A, Bouthour W, Tomkova Chaoui E, Maling N, Nguyen TAK, Momjian S, Vargas Gomez MI, Zacharia A, Bally JF, Fleury V, Tatu L, Burkhard PR, Krack P.
PMID: 32714264
Front Neurol. 2020 Jul 02;11:532. doi: 10.3389/fneur.2020.00532. eCollection 2020.

No abstract available.

Cite
Béreau M, Kibleur A, Bouthour W, et al. Modeling of Electric Fields in Individual Imaging Atlas for Capsular Threshold Prediction of Deep Brain Stimulation in Parkinson's Disease: A Pilot Study. Front Neurol. 2020;11:532doi: 10.3389/fneur.2020.00532.
Béreau, M., Kibleur, A., Bouthour, W., Tomkova Chaoui, E., Maling, N., Nguyen, T. A. K., Momjian, S., Vargas Gomez, M. I., Zacharia, A., Bally, J. F., Fleury, V., Tatu, L., Burkhard, P. R., & Krack, P. (2020). Modeling of Electric Fields in Individual Imaging Atlas for Capsular Threshold Prediction of Deep Brain Stimulation in Parkinson's Disease: A Pilot Study. Frontiers in neurology, 11532. https://doi.org/10.3389/fneur.2020.00532
Béreau, Matthieu, et al. "Modeling of Electric Fields in Individual Imaging Atlas for Capsular Threshold Prediction of Deep Brain Stimulation in Parkinson's Disease: A Pilot Study." Frontiers in neurology vol. 11 (2020): 532. doi: https://doi.org/10.3389/fneur.2020.00532
Béreau M, Kibleur A, Bouthour W, Tomkova Chaoui E, Maling N, Nguyen TAK, Momjian S, Vargas Gomez MI, Zacharia A, Bally JF, Fleury V, Tatu L, Burkhard PR, Krack P. Modeling of Electric Fields in Individual Imaging Atlas for Capsular Threshold Prediction of Deep Brain Stimulation in Parkinson's Disease: A Pilot Study. Front Neurol. 2020 Jul 02;11:532. doi: 10.3389/fneur.2020.00532. eCollection 2020. PMID: 32714264; PMCID: PMC7343907.
Copy Download .nbib Format: NLM
Differential Regulation of Cellular FAM111B by Human Adenovirus C Type 5 E1 Oncogenes.

Viruses

Ip WH, Wilkens B, Solomatina A, Martin J, Melling M, Hidalgo P, Bertzbach LD, Speiseder T, Dobner T.
PMID: 34071532
Viruses. 2021 May 28;13(6). doi: 10.3390/v13061015.

The adenovirus type 5 (HAdV-C5) E1 transcription unit encodes regulatory proteins that are essential for viral replication and transformation. Among these, E1A and E1B-55K act as key multifunctional HAdV-C5 proteins involved in various steps of the viral replication cycle...

Cite
Ip WH, Wilkens B, Solomatina A, et al. Differential Regulation of Cellular FAM111B by Human Adenovirus C Type 5 E1 Oncogenes. Viruses. 2021;13(6)doi: 10.3390/v13061015.
Ip, W. H., Wilkens, B., Solomatina, A., Martin, J., Melling, M., Hidalgo, P., Bertzbach, L. D., Speiseder, T., & Dobner, T. (2021). Differential Regulation of Cellular FAM111B by Human Adenovirus C Type 5 E1 Oncogenes. Viruses, 13(6), . https://doi.org/10.3390/v13061015
Ip, Wing-Hang, et al. "Differential Regulation of Cellular FAM111B by Human Adenovirus C Type 5 E1 Oncogenes." Viruses vol. 13,6 (2021). doi: https://doi.org/10.3390/v13061015
Ip WH, Wilkens B, Solomatina A, Martin J, Melling M, Hidalgo P, Bertzbach LD, Speiseder T, Dobner T. Differential Regulation of Cellular FAM111B by Human Adenovirus C Type 5 E1 Oncogenes. Viruses. 2021 May 28;13(6). doi: 10.3390/v13061015. PMID: 34071532; PMCID: PMC8227810.
Copy Download .nbib Format: NLM
The Potential for Decision Support Tools to Improve the Management of Root-Feeding Fly Pests of Vegetables in Western Europe.

Insects

Collier R, Mazzi D, Folkedal Schjøll A, Schorpp Q, Thöming G, Johansen TJ, Meadow R, Meyling NV, Cortesero AM, Vogler U, Gaffney MT, Hommes M.
PMID: 32545796
Insects. 2020 Jun 13;11(6). doi: 10.3390/insects11060369.

Several important vegetable crops grown outdoors in temperate climates in Europe can be damaged by the root-feeding larvae of Diptera (

Cite
Collier R, Mazzi D, Folkedal Schjøll A, et al. The Potential for Decision Support Tools to Improve the Management of Root-Feeding Fly Pests of Vegetables in Western Europe. Insects. 2020;11(6)doi: 10.3390/insects11060369.
Collier, R., Mazzi, D., Folkedal Schjøll, A., Schorpp, Q., Thöming, G., Johansen, T. J., Meadow, R., Meyling, N. V., Cortesero, A. M., Vogler, U., Gaffney, M. T., & Hommes, M. (2020). The Potential for Decision Support Tools to Improve the Management of Root-Feeding Fly Pests of Vegetables in Western Europe. Insects, 11(6), . https://doi.org/10.3390/insects11060369
Collier, Rosemary, et al. "The Potential for Decision Support Tools to Improve the Management of Root-Feeding Fly Pests of Vegetables in Western Europe." Insects vol. 11,6 (2020). doi: https://doi.org/10.3390/insects11060369
Collier R, Mazzi D, Folkedal Schjøll A, Schorpp Q, Thöming G, Johansen TJ, Meadow R, Meyling NV, Cortesero AM, Vogler U, Gaffney MT, Hommes M. The Potential for Decision Support Tools to Improve the Management of Root-Feeding Fly Pests of Vegetables in Western Europe. Insects. 2020 Jun 13;11(6). doi: 10.3390/insects11060369. PMID: 32545796; PMCID: PMC7349907.
Copy Download .nbib Format: NLM
Acute Polyradiculomyelitis With Spinal Cord Gray Matter Lesions: A Report of Two Cases.

Frontiers in neurology

Tsagkas C, Wendebourg MJ, Mehling M, Lorscheider J, Lyrer P, Décard BF.
PMID: 34489856
Front Neurol. 2021 Aug 19;12:721669. doi: 10.3389/fneur.2021.721669. eCollection 2021.

No abstract available.

Cite
Tsagkas C, Wendebourg MJ, Mehling M, et al. Acute Polyradiculomyelitis With Spinal Cord Gray Matter Lesions: A Report of Two Cases. Front Neurol. 2021;12:721669doi: 10.3389/fneur.2021.721669.
Tsagkas, C., Wendebourg, M. J., Mehling, M., Lorscheider, J., Lyrer, P., & Décard, B. F. (2021). Acute Polyradiculomyelitis With Spinal Cord Gray Matter Lesions: A Report of Two Cases. Frontiers in neurology, 12721669. https://doi.org/10.3389/fneur.2021.721669
Tsagkas, Charidimos, et al. "Acute Polyradiculomyelitis With Spinal Cord Gray Matter Lesions: A Report of Two Cases." Frontiers in neurology vol. 12 (2021): 721669. doi: https://doi.org/10.3389/fneur.2021.721669
Tsagkas C, Wendebourg MJ, Mehling M, Lorscheider J, Lyrer P, Décard BF. Acute Polyradiculomyelitis With Spinal Cord Gray Matter Lesions: A Report of Two Cases. Front Neurol. 2021 Aug 19;12:721669. doi: 10.3389/fneur.2021.721669. eCollection 2021. PMID: 34489856; PMCID: PMC8416670.
Copy Download .nbib Format: NLM
Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study.

Open heart

Brecker S, Mealing S, Padhiar A, Eaton J, Sculpher M, Busca R, Bosmans J, Gerckens UJ, Wenaweser P, Tamburino C, Bleiziffer S, Piazza N, Moat N, Linke A.
PMID: 25349700
Open Heart. 2014 Oct 23;1(1):e000155. doi: 10.1136/openhrt-2014-000155. eCollection 2014.

OBJECTIVE: To use patient-level data from the ADVANCE study to evaluate the cost-effectiveness of transcatheter aortic valve implantation (TAVI) compared to medical management (MM) in patients with severe aortic stenosis from the perspective of the UK NHS.METHODS: A published...

Cite
Brecker S, Mealing S, Padhiar A, et al. Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study. Open Heart. 2014;1(1):e000155doi: 10.1136/openhrt-2014-000155.
Brecker, S., Mealing, S., Padhiar, A., Eaton, J., Sculpher, M., Busca, R., Bosmans, J., Gerckens, U. J., Wenaweser, P., Tamburino, C., Bleiziffer, S., Piazza, N., Moat, N., & Linke, A. (2014). Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study. Open heart, 1(1), e000155. https://doi.org/10.1136/openhrt-2014-000155
Brecker, Stephen, et al. "Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study." Open heart vol. 1,1 (2014): e000155. doi: https://doi.org/10.1136/openhrt-2014-000155
Brecker S, Mealing S, Padhiar A, Eaton J, Sculpher M, Busca R, Bosmans J, Gerckens UJ, Wenaweser P, Tamburino C, Bleiziffer S, Piazza N, Moat N, Linke A. Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study. Open Heart. 2014 Oct 23;1(1):e000155. doi: 10.1136/openhrt-2014-000155. eCollection 2014. PMID: 25349700; PMCID: PMC4207938.
Copy Download .nbib Format: NLM
Simulation Experiences in Canadian Physiotherapy Programmes: A Description of Current Practices.

Physiotherapy Canada. Physiotherapie Canada

Melling M, Duranai M, Pellow B, Lam B, Kim Y, Beavers L, Miller E, Switzer-McIntyre S.
PMID: 30275651
Physiother Can. 2018;70(3):262-271. doi: 10.3138/ptc.2017-11.e.

No abstract available.

Cite
Melling M, Duranai M, Pellow B, et al. Simulation Experiences in Canadian Physiotherapy Programmes: A Description of Current Practices. Physiother Can. 2018;70(3):262-271doi: 10.3138/ptc.2017-11.e.
Melling, M., Duranai, M., Pellow, B., Lam, B., Kim, Y., Beavers, L., Miller, E., & Switzer-McIntyre, S. (2018). Simulation Experiences in Canadian Physiotherapy Programmes: A Description of Current Practices. Physiotherapy Canada. Physiotherapie Canada, 70(3), 262-271. https://doi.org/10.3138/ptc.2017-11.e
Melling, Meaghan, et al. "Simulation Experiences in Canadian Physiotherapy Programmes: A Description of Current Practices." Physiotherapy Canada. Physiotherapie Canada vol. 70,3 (2018): 262-271. doi: https://doi.org/10.3138/ptc.2017-11.e
Melling M, Duranai M, Pellow B, Lam B, Kim Y, Beavers L, Miller E, Switzer-McIntyre S. Simulation Experiences in Canadian Physiotherapy Programmes: A Description of Current Practices. Physiother Can. 2018;70(3):262-271. doi: 10.3138/ptc.2017-11.e. PMID: 30275651; PMCID: PMC6158570.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 53 entries